Plasmodium spp.


Download Plasmodium PDF


Characteristics

Morphology

Plasmodium is an apicomplexan parasite. The asexual stage in the vertebrate host needs the red blood cell (RBC) to survive. Various forms develop inside the RBC, namely, trophozoites, schizonts and merozoites. P. vivax and P. ovale, leave dormant forms in the liver called hypnozoites. The sexual stages responsible for transmission to other vertebrate host are the male and female gametocytes which are picked up by the female Anopheles mosquito when drawing a blood meal. The oocysts develop in the midgut of the mosquito and ultimately sporozoites are stored in the salivary glands until the next blood meal.

Growth Conditions

There are adapted strains of P. falciparum and P. knowlesi, which can be continuously propagated in vitro by adding human or rhesus RBCs. Other species may be maintained in vitro for a short period of time.

Generic Conditions

Transgenic Plasmodium parasites can be generated by double cross-over recombination and insertion of a drug-resistance cassette. The selection drugs are Pyrimethamine and/or PS-15, and the transgenic parasites retain their susceptibility to Chloroquine and Artemisinin derivatives.


Health Hazards

Host Range

There are more than 100 species of Plasmodium, which infect a wide range of vertebrates. Five species are recognized to infect humans: P. falciparum, P. vivax, P. malariae, P. ovale, and. P. knowlesi (known to infect macaques, is now recognized to cause a zoonotic infection in humans). 

Modes of Transmission

Plasmodium is a blood-borne pathogen and it can be transmitted via an infected mosquito bite, transfusion, and needle stick.

Signs and Symptoms

Initial merozoites are released from the liver into the blood stream to target RBCs. Symptoms appear when new merozoites are released every other day (P. knowlesi), every second day (tertian P. falciparum, P. vivax, P. ovale) or every third day (quartan, P. malariae) Signs include fever, chills, body ache, sweats, headache

Infectious Dose

The infectious dose depends on the route of inoculation. A minimal number of Plasmodium-infected RBCs is needed to initiate an infection. If the infection is initiated by a mosquito bite, the number of sporozoites to be injected will depend on the species of parasite.

Incubation Period

The liver infection initiated by sporozoites injected during a mosquito bite is asymptomatic and may last up to 30 days, depending on the Plasmodium species.


Medical Precautions/Treatment

Prophylaxis

US travelers are advised to follow the CDC recommendations before traveling, during their stay in a malaria endemic area, and after they return to the US.

Vaccines

There is no vaccine available

Diagnosis and Treatment

The diagnostic tool of preference is the thick blood smear. Antimalarial treatment will be dictated by the species of Plasmodium, the resistance profile of the parasite, the age group of the patient, and severity of disease. If the infection is caused by hypnozoite-causing species, Primaquine will need to be administered to treat these stages, and the individual should be screened for G6PD deficiencies prior to treatment.

Surveillance

Malaria is a reportable disease in the US and territories

Emory Requirements

Report all incidents using PeopleSoft


Laboratory Hazards

Laboratory Acquired Infections (LAIs)

LAIs have been reported by various human and simian Plasmodium species

Sources

Needle stick injury, barehanded work, contact with open wound, contact with infected blood, infected vector from a mosquito colony


Supplemental References

CDC

Malaria Information 

BMBL

Biosafety in Microbiological and Biomedical Laboratories/


Containment

BSL-2

All work with Plasmodium-infected samples or propagation of parasites must be conducted inside a Biological safety Cabinet (BSC) Class II. Use face shield for open bench work.


Spill Procedures

Small

Notify others working in the lab. Allow aerosols to settle. Don appropriate PPE. Cover area of the spill with paper towels and apply an EPA approved disinfectant, working from the perimeter towards the center. Allow 30 minutes of contact time before disposal and cleanup of spill materials.

Large

Contact Emory's Biosafety Officer (404-727-8863),
the EHSO Office (404-727-5922), or
The Spill Response Team (404-727-2888).


Exposure Procedures

Mucous membrane

Flush eyes, mouth or nose for 15 minutes at eyewash station.

Other Exposures

Wash area with soap and water for 15 minutes.

Reporting

Immediately report incident to supervisor, complete an employee incident report using PeopleSoft.

Medical Followup 

7am-4pm (OIM): EUH (404-686-7941) EUHM (404-686-7106) WW (404-728-6431)

After Hours: OIM NP On Call 404-686-5500 PIC# 50464

Needle Stick (OIM): EUH (404-686-8587) EUHM (404-686-2352)

Yerkes: Maureen Thompson Office (404-727-8012) Cell (404-275-0963)


Viability

Disinfection

Plasmodium is susceptible to 70% ethanol and freshly made 10% hypochlorite

Inactivation

Plasmodium is susceptible to heat inactivation

Survival Outside Host

Minimal


Personal Protective Equipment (PPE)

Minimum PPE Requirements

At minimum, personnel are required to don gloves, closed toed shoes, lab coat, and appropriate face and eye protection prior to working with Plasmodium-infected samples. ;Additional PPE may be required depending on lab specific SOPs.

Additional Precautions

All procedures that may produce aerosols, or involve high concentrations or large volumes should be done in a BSC. The use of needles, syringes, and other sharp objects should be strictly limited. Additional precautions should be considered with work involving animals or large-scale activities.